Financials
- Market Capitalization 1.75 B
- Employee 260
- Founded 1997
- CEO N/A
- Website www.xencor.com
- Headquarter Delaware, United States
- FIGI BBG0026ZG4W0
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-12.35
Relación precio/flujo de caja
9.05
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2024 | ZYME Zymeworks Inc. - Common Stock | 25.07 USD | -1.03% | -2.64% | -5.93% | +41.32% | 1.78 B USD | ||
| 2033 | TRVI Trevi Therapeutics, Inc. - Common Stock | 12.29 USD | -4.95% | -5.10% | -22.61% | +19.32% | 1.75 B USD | ||
| 2035 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 16.51 USD | -5.33% | -4.46% | -20.66% | -24.13% | 1.74 B USD | ||
| 2042 | BHVN Biohaven Ltd. Common Shares | 11.42 USD | -3.22% | -3.71% | -9.37% | -32.59% | 1.72 B USD |